Evercyte
Combined capabilities provide scientists with access to new and existing immortalized cell lines for use in broad research applications and clinical markets.
| 2 min read
VelaLabs, a provider of analytical services to the global biopharmaceutical industry, and Evercyte, a producer of standardized, relevant cell systems, today (Sept. 3) announced that they have entered into a cooperation to commercialize immortalized target cells for the characterization of biosimilars in a GMP environment.
| 1 min read
Page 1 of 1 - 2 Total Items
